| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $277.2M | +19.4% |
| R&D Expense | $61.5M | +12.1% |
| SG&A Expense | $170.4M | +11.4% |
| Operating Income | -$4.1M | +88.9% |
| Interest Expense | $6.8M | +0.5% |
| Pre-tax Income | $30.9M | +806.5% |
| Income Tax | $3.5M | +75.4% |
| Net Income | $27.3M | +527.4% |
| EPS (Basic) | $0.21 | +520.0% |
| EPS (Diluted) | $0.20 | +500.0% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $95.9M | -36.2% |
| Accounts Receivable | $45.3M | +11.5% |
| Inventory | $70.1M | +31.5% |
| Current Assets | $848.9M | -1.2% |
| Total Assets | $986.3M | -1.1% |
| Current Liabilities | $78.6M | +26.4% |
| Total Liabilities | $389.5M | +3.8% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $66.5M | -33.9% |
| Capital Expenditures | $6.4M | +54.8% |
| Investing Cash Flow | -$18.0M | +88.3% |
| Financing Cash Flow | -$102.0M | -7460.5% |
| Free Cash Flow | $60.2M | -37.6% |
| Stockholders' Equity |
| $596.8M |
| -4.1% |